Tag: Mylan
Teva’s Recovery Hopes Mired in Staggering Antitrust Lawsuit, $26.7 Billion Debt
“Teva is a consistent participant in the conspiracies identified in this complaint, but the conduct is pervasive and industry-wide.”
Teva to Buy Allergan for $40 Billion
Israel's giant generic firm will withdraw its troublesome bid for Mylan.